03Jul
Committed to Clarity: FDA’s Dedication to Transparency with the End of ASR
On June 21, the Food and Drug Administration (FDA) released a report titled “Statement on agency’s efforts to increase transparency in medical device reporting.” This report describes updates to FDA’s Medical Device Reporting (MDR) Program, namely...
By:
Morrison & Foerster LLP
Related
The CFPB recently released two guides addressing the disclosures required for construction-only and ...
Read More >
WASHINGTON - The U.S. Equal Employment Opportunity Commission (EEOC) today released detailed breakdo...
Read More >
The federal agency overseeing mine safety and health has been undergoing a bit of a transformation o...
Read More >
On August 9, 2019, we explained that the National Labor Relations Board (NLRB) would be publishing a...
Read More >
Thomas J. Szymanski Effective January 1, 2020, private employers in New Jersey are prohibited from a...
Read More >
The autumn leaves are turning, football season is gathering momentum, Congress is reconvening, and a...
Read More >